Become a partner

The DETERMINE trial platform enables the rapid testing of licensed targeted cancer drugs in unlicensed cancer indications. 

We are seeking additional licensed targeted drugs from pharmaceutical and biotech companies and welcome enquiries about being included in the study.

By completing this form you consent to a member of the DETERMINE team getting in touch regarding your enquiry.